1 / 10

Supplementary Figure 1

Supplementary Figure 1. Supplementary Figure 2. Supplementary Table 1: Classification of patients based on receptor and disease status. Supplementary Table 2 Comparison between two detection techniques. Abbreviations: CSV= Cell-surface vimentin, CK= Cytokeratin,.

bradford-jerry
Télécharger la présentation

Supplementary Figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 1

  2. Supplementary Figure 2

  3. Supplementary Table 1: Classification of patients based on receptor and disease status

  4. Supplementary Table 2 Comparison between two detection techniques Abbreviations: CSV= Cell-surface vimentin, CK= Cytokeratin,

  5. Supplementary Table 3 Concordances between CSV and CellSearch detection techniques Abbreviations: CSV= Cell-surface vimentin, CTC= Circulating tumor cells.

  6. Supplementary Table 4: Receptor based classification for individual samples with stable/progression status as determined by both techniques CSV: Cell-surface vimentin; CTCs: Circulating tumor cells; ER: Estrogen receptor; PR: Progesterone receptor ; HER2: HER2/neu receptor; Triple negative: ER- PR- HER2-; Luminal A: ER/PR+ HER2-Luminal B: ER/PR+ HER2+, HER2 Type: ER/PR- HER2+

  7. Supplementary Table 5: Analysis of Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value based on receptor status of patients CSV: Cell-surface vimentin Summation: sum of CTC counts from 84-1 and CellSearch methods. Triple negative: ER- PR- HER2-; Luminal A: ER/PR+ HER2-Th 5 indicates a threshold of 5 CTCs/ 7.5 mL as cutoff. Th 8 indicates a threshold of 8 CTCs/ 7.5 mL as cutoff.

  8. Supplementary Table 6: Analysis of Nuclear EpCAM Status

  9. Supplementary Table 7: Sensitivity, Specificity, Positive prediction and Negative prediction values for Nuclear EpCAM method

  10. Supplementary Table 8: Clinical parameters, disease status and CTC counts from patients

More Related